Researchers find prostate cancer drug byproduct can fuel cancer cells

by Cleveland ClinicNima Sharifi, MD, Cleveland Clinic Lerner Research Institute. Credit: Cleveland ClinicA genetic anomaly in certain men with prostate cancer may impact their response to common

Updated on: June 15,2024 3

Researchers find prostate cancer drug byproduct can fuel cancer cells

by Cleveland ClinicNima Sharifi, MD, Cleveland Clinic Lerner Research Institute. Credit: Cleveland ClinicA genetic anomaly in certain men with prostate cancer may impact their response to common

Updated on:June 15,2024 3

Researchers develop new one-two punch against melanoma in mouse model

by Johns Hopkins University School of MedicineCredit: Kimmel Cancer CenterResearchers at the Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins and the Johns Hopkins University

Updated on: June 04,2024 6

Researchers develop new one-two punch against melanoma in mouse model

by Johns Hopkins University School of MedicineCredit: Kimmel Cancer CenterResearchers at the Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins and the Johns Hopkins University

Updated on:June 04,2024 6

Researchers discover new genetic link to premenopausal breast cancer

by University of Alberta Faculty of Medicine & DentistryGraduate student Mahalakshmi Kumaran (left) and professor Sambasivarao Damaraju led a team that discovered a new genetic marker linked

Updated on: June 22,2024 8

Researchers discover new genetic link to premenopausal breast cancer

by University of Alberta Faculty of Medicine & DentistryGraduate student Mahalakshmi Kumaran (left) and professor Sambasivarao Damaraju led a team that discovered a new genetic marker linked

Updated on:June 22,2024 8

Oncolytic virus treatment produces promising results in patients with triple-negative breast cancer

byH. Lee Moffitt Cancer Center & Research InstituteCredit: Unsplash/CC0 Public DomainTriple-negative breast cancer accounts for approximately 15% of all breast cancer cases. Patients with th

Updated on: January 02,2024 9

Oncolytic virus treatment produces promising results in patients with triple-negative breast cancer

byH. Lee Moffitt Cancer Center & Research InstituteCredit: Unsplash/CC0 Public DomainTriple-negative breast cancer accounts for approximately 15% of all breast cancer cases. Patients with th

Updated on:January 02,2024 9

Expert highlights the importance of lung cancer screening

by Deb Balzer, Mayo Clinic News NetworkCredit: Unsplash/CC0 Public DomainScreening for lung cancer can save lives, and there's an urgent need for more screening of people of color. That's one

Updated on: April 07,2024 20

Expert highlights the importance of lung cancer screening

by Deb Balzer, Mayo Clinic News NetworkCredit: Unsplash/CC0 Public DomainScreening for lung cancer can save lives, and there's an urgent need for more screening of people of color. That's one

Updated on:April 07,2024 20

Researchers develop 'on-demand' whole tumor cell vaccine against cancer

by Chinese Academy of SciencesStrategy of using photothermal nanoparticle-based whole tumor cell vaccine (LN-TCV) for on-demand near-infrared (NIR) manipulation of immune responses against cancer

Updated on: February 18,2024 11

Researchers develop 'on-demand' whole tumor cell vaccine against cancer

by Chinese Academy of SciencesStrategy of using photothermal nanoparticle-based whole tumor cell vaccine (LN-TCV) for on-demand near-infrared (NIR) manipulation of immune responses against cancer

Updated on:February 18,2024 11

Scientists consider fighting potentially lethal form of breast cancer with chemical produced by the disease

by Delthia Ricks , Medical XpressSchematic model of GDP-M regulating HRD and immunity through promoting BRCA2 degradation. Credit:Science Translational Medicine(2024). DOI: 10.1126/scitran

Updated on: March 30,2024 0

Scientists consider fighting potentially lethal form of breast cancer with chemical produced by the disease

by Delthia Ricks , Medical XpressSchematic model of GDP-M regulating HRD and immunity through promoting BRCA2 degradation. Credit:Science Translational Medicine(2024). DOI: 10.1126/scitran

Updated on:March 30,2024 0

Second primary malignancies represent small proportion of adverse events after CAR T-cell therapy

by Elana GotkineSecond primary malignancies (SPMs) represent a small proportion of adverse events (AEs) reported by patients receiving chimeric antigen receptor T-cell (CAR T-cell) therapy, according

Updated on: March 30,2024 0

Second primary malignancies represent small proportion of adverse events after CAR T-cell therapy

by Elana GotkineSecond primary malignancies (SPMs) represent a small proportion of adverse events (AEs) reported by patients receiving chimeric antigen receptor T-cell (CAR T-cell) therapy, according

Updated on:March 30,2024 0

Researchers find link between obesity and blood cancer

by Jackie Maupin,Indiana University School of MedicineCredit: Unsplash/CC0 Public DomainIndiana University School of Medicine researchers studying clonal hematopoiesis of indeterminate potential

Updated on: February 01,2024 16

Researchers find link between obesity and blood cancer

by Jackie Maupin,Indiana University School of MedicineCredit: Unsplash/CC0 Public DomainIndiana University School of Medicine researchers studying clonal hematopoiesis of indeterminate potential

Updated on:February 01,2024 16

BMI's relation to cancer therapy mortality risks not so straightforward, study finds

byOsaka Metropolitan UniversityFor non-small cell lung cancer treatment, immunotherapy seems to pose less risk for persons under a certain BMI, while conventional chemotherapy appears optimal fo

Updated on: September 27,2024 0

BMI's relation to cancer therapy mortality risks not so straightforward, study finds

byOsaka Metropolitan UniversityFor non-small cell lung cancer treatment, immunotherapy seems to pose less risk for persons under a certain BMI, while conventional chemotherapy appears optimal fo

Updated on:September 27,2024 0

Over half of English patients with NSCLC in areas with low socio-economic levels do not receive anti-cancer therapies

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainNovel anti-cancer therapies were not accessible to more than half of the patients in England who were diagnose

Updated on: February 01,2024 17

Over half of English patients with NSCLC in areas with low socio-economic levels do not receive anti-cancer therapies

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainNovel anti-cancer therapies were not accessible to more than half of the patients in England who were diagnose

Updated on:February 01,2024 17

Study explores why patients skip appointments for suspected cancer

by Shelley Hughes,University of YorkCredit: CC0 Public DomainMen, the elderly and people from deprived areas are among the patients most likely to miss an urgent referral appointment for suspect

Updated on: May 21,2024 6

Study explores why patients skip appointments for suspected cancer

by Shelley Hughes,University of YorkCredit: CC0 Public DomainMen, the elderly and people from deprived areas are among the patients most likely to miss an urgent referral appointment for suspect

Updated on:May 21,2024 6